Company intelligence / Profile preview
Lunan Pharmaceutical Group
Chinalunanpharma.com ↗
- Ownership
- Private
- Employees
- ~5000
- Development stage
- Commercial
01
Overview
Lunan Pharmaceutical Group has multiple approved drugs in China, Japan, and the United States, including small molecules and biologics. The company has obtained 4 European and American preparation approvals, 6 CEP certificates, and 28 American DMF registrations
- Therapeutic areas
- PulmonologyOncologyHematologyOtherDermatologyGastroenterologyCardiovascularNephrologyInfectious Diseases
- Modalities
- Small molecule drugsHerbal medicineMonoclonal antibodiesBiosimilarsBispecific T-cell Engagers (BiTE)ADC (Antibody-Drug Conjugates)
- Industry
- Pharma
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Adcoris Biopharma Co., LTD. (strategic collaboration for ADC product co-development)
Beyond the preview
Go deeper on Lunan Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lunan Pharmaceutical Group.